Stocky turns companies like Tyra Biosciences, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Tyra Biosciences, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Company can now raise more money by selling additional shares to fund operations and growth.
Quarterly earnings announcements show investors how the company is performing financially.
Quarterly earnings announcements show investors how the company is performing financially.
Director elections determine who leads the company's board and makes major decisions.
Adding directors brings new leadership perspectives and skills to guide company strategy.
Stocky reads Tyra Biosciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Tyra Biosciences, Inc.'s most recent tracked filing was a 424B5 on 4 Aug 2026: Increases stock offering capacity to $250 million total.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
This page is just a preview. Open the live, interactive version for the full picture:
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.